Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helga Westerlind

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
The American Journal of Gastroenterology|August 3, 2016
HLA Associations Distinguish Collagenous From Lymphocytic ColitisHelga Westerlind, Ferdinando Bonfiglio, Marie-Rose Mellander, et al.
European Journal of Human Genetics : EJHG|August 28, 2014
Identity-by-descent mapping in a Scandinavian multiple sclerosis cohortHelga Westerlind, Kerstin Imrell, Ryan Ramanujam, et al.
Rheumatology (Oxford, England)|October 18, 2022
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritisHelga Westerlind, Alf Kastbom, Johan Rönnelid, et al.
Annals of the Rheumatic Diseases|December 5, 2023
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammationEleftheria Pertsinidou, Saedis Saevarsdottir, Vivek Anand Manivel, et al.
Frontiers in Medicine|April 13, 2023
Molecular signature of methotrexate response among rheumatoid arthritis patientsBoel Brynedal, Niyaz Yoosuf, Tinna Bjorg Ulfarsdottir, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 21, 2025
Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the HLA Class II Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid ArthritisLinda Mathsson Alm, Helga Westerlind, Isabel Gehring, et al.
Rheumatology (Oxford, England)|June 16, 2023
Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritisAnton Öberg Sysojev, Saedis Saevarsdottir, Lina-Marcela Diaz-Gallo, et al.
Scandinavian Journal of Public Health|December 9, 2024
Legal obstacles jeopardise research in personalised medicine - experiences from a Nordic collaboration within rheumatologyBente Glintborg, Mats Hansson, Hilde Berner Hammer, et al.
Molecular Medicine (Cambridge, Mass.)|August 18, 2016
Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE studyLasse Folkersen, Boel Brynedal, Lina Marcela Diaz-Gallo, et al.
American Journal of Human Genetics|September 3, 2019
Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological SubphenotypeChikashi Terao, Boel Brynedal, Zuomei Chen, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
The American Journal of Gastroenterology|August 3, 2016
HLA Associations Distinguish Collagenous From Lymphocytic ColitisHelga Westerlind, Ferdinando Bonfiglio, Marie-Rose Mellander, et al.
European Journal of Human Genetics : EJHG|August 28, 2014
Identity-by-descent mapping in a Scandinavian multiple sclerosis cohortHelga Westerlind, Kerstin Imrell, Ryan Ramanujam, et al.
Rheumatology (Oxford, England)|October 18, 2022
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritisHelga Westerlind, Alf Kastbom, Johan Rönnelid, et al.
Annals of the Rheumatic Diseases|December 5, 2023
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammationEleftheria Pertsinidou, Saedis Saevarsdottir, Vivek Anand Manivel, et al.
Frontiers in Medicine|April 13, 2023
Molecular signature of methotrexate response among rheumatoid arthritis patientsBoel Brynedal, Niyaz Yoosuf, Tinna Bjorg Ulfarsdottir, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 21, 2025
Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the HLA Class II Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid ArthritisLinda Mathsson Alm, Helga Westerlind, Isabel Gehring, et al.
Rheumatology (Oxford, England)|June 16, 2023
Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritisAnton Öberg Sysojev, Saedis Saevarsdottir, Lina-Marcela Diaz-Gallo, et al.
Scandinavian Journal of Public Health|December 9, 2024
Legal obstacles jeopardise research in personalised medicine - experiences from a Nordic collaboration within rheumatologyBente Glintborg, Mats Hansson, Hilde Berner Hammer, et al.
Molecular Medicine (Cambridge, Mass.)|August 18, 2016
Integration of known DNA, RNA and protein biomarkers provides prediction of anti-TNF response in rheumatoid arthritis: results from the COMBINE studyLasse Folkersen, Boel Brynedal, Lina Marcela Diaz-Gallo, et al.
American Journal of Human Genetics|September 3, 2019
Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological SubphenotypeChikashi Terao, Boel Brynedal, Zuomei Chen, et al.
Pageof 7